Tesamorelin phase 4 trial!
I didn't know there was an ongoing trial by Columbia University studying Tesamorelin's effect on liver fat, VAT, inflammatory gens etc. among PLWH.
Only 24 participants, open label, phase4!!
Body Composition and Adipose Tissue in HIV - Full Text View - ClinicalTrials.gov
"In this study, the investigators will examine the effect of therapy with the Growth Hormone Releasing Hormone (GHRH) analog tesamorelin on body composition in patients with HIV lipodystrophy and central adiposity. This study is a single arm prospective study of tesamorelin therapy of patients with HIV lipodystrophy. Subjects will do body composition testing, adipose tissue biopsy, metabolic rate measurements and insulin sensitivity assessment before, 6 and 12 months after daily injections of tesamorelin 2 mg by subcutaneous injection."